{
    "clinical_study": {
        "@rank": "144682", 
        "arm_group": [
            {
                "arm_group_label": "Double lumen tube", 
                "arm_group_type": "Experimental", 
                "description": "This arm contains patients who are needed endobronchial intubation with double lumen tube for general anesthesia. After propofol infusion of effect site concentration 4 \u03bcg/ml, remifentanil infusion will be started with effect site concentration of 3.5 ng/ml. According to change arterial blood pressure and heart rate from baseline value, next remifentanil concentration will be regulated using up-and-down method. Step size of dose is 0.5 ng/ml."
            }, 
            {
                "arm_group_label": "single lumen tube", 
                "arm_group_type": "Active Comparator", 
                "description": "This arm contains patients who are needed endotracheal intubation with single lumen tube for general anesthesia. After propofol infusion of effect site concentration 4 \u03bcg/ml, remifentanil infusion will be started with effect site concentration of 3.5 ng/ml. According to change arterial blood pressure and heart rate from baseline value, next remifentanil concentration will be regulated using up-and-down method. Step size of dose is 0.5 ng/ml."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is the comparison of the effect-site concentration of remifentanil\n      for blunting hemodynamic responses to ordinary tracheal and double-lumen endobronchial\n      intubation during propofol-remifentanil total intravenous anesthesia."
        }, 
        "brief_title": "Effect-site Concentration of Remifentanil for Blunting Hemodynamic Responses to Double-lumen Endobronchial Intubation", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Intubation, Intratracheal", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patient who is needed intubation for general anesthesia\n\n        Exclusion Criteria:\n\n          -  patient who is anticipating difficult airway\n\n          -  patient who takes any drug to influence this study\n\n          -  cardiovascular disease, renal disease, liver disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02001285", 
            "org_study_id": "HJKim2"
        }, 
        "intervention": {
            "arm_group_label": [
                "Double lumen tube", 
                "single lumen tube"
            ], 
            "description": "During intubation, remifentanil will be infused to prevent change arterial blood pressure and heart rate.", 
            "intervention_name": "Remifentanil", 
            "intervention_type": "Drug", 
            "other_name": "Ultiva (TM)"
        }, 
        "intervention_browse": {
            "mesh_term": "Remifentanil"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "remifentanil", 
        "lastchanged_date": "November 27, 2013", 
        "location": {
            "contact": {
                "email": "hjanesthesia@empas.com", 
                "last_name": "Hyun Jung Kim, MD, PhD", 
                "phone": "82-64-717-2026"
            }, 
            "facility": {
                "address": {
                    "city": "Jeju-si", 
                    "country": "Korea, Republic of", 
                    "state": "Jeju Special Self-Governing Province", 
                    "zip": "690-767"
                }, 
                "name": "Jeju National University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of the Effect-site Concentration of Remifentanil for Blunting Hemodynamic Responses to Ordinary Tracheal and Double-lumen Endobronchial Intubation During Propofol-remifentanil Total Intravenous Anesthesia", 
        "overall_contact": {
            "email": "hjanesthesia@empas.com", 
            "last_name": "Hyun Jung Kim, MD, PhD", 
            "phone": "82-64-717-2026"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Arterial blood pressure will be recorded before anesthesia, after propofol infusion, after remifentanil infusion and after intubation during 3 min with 1 min interval.", 
            "measure": "arterial blood pressure", 
            "safety_issue": "Yes", 
            "time_frame": "Change from baseline in arterial blood pressure at intubation period"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02001285"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Jeju National University School of Medicine", 
            "investigator_full_name": "Hyun Jung Kim", 
            "investigator_title": "Assistant professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Heart rate will be recorded before anesthesia, after propofol infusion, after remifentanil infusion and after intubation during 3 min with 1 min interval.", 
            "measure": "heart rate", 
            "safety_issue": "Yes", 
            "time_frame": "Change from baseline in heart rate at intubation period"
        }, 
        "source": "Jeju National University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Jeju National University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}